n(omega)-hydroxyarginine has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chénais, B; Lepoivre, M; Tenu, JP; Yapo, A | 1 |
1 other study(ies) available for n(omega)-hydroxyarginine and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
N omega-hydroxy-L-arginine, a reactional intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Biological Transport; Cell Division; Cell Line; Cell Survival; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Experimental; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase; Tumor Cells, Cultured | 1993 |